SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by IFP Advisors Inc

IFP Advisors Inc increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 68.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,317 shares of the exchange traded fund’s stock after acquiring an additional 1,747 shares during the period. IFP Advisors Inc’s holdings in SPDR S&P Biotech ETF were worth $389,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of XBI. Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at $29,000. Avior Wealth Management LLC grew its holdings in SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC grew its holdings in SPDR S&P Biotech ETF by 101.5% in the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. acquired a new stake in SPDR S&P Biotech ETF in the third quarter valued at $40,000. Finally, Bank of Jackson Hole Trust acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at $43,000.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $88.71 on Friday. The firm has a market capitalization of $5.85 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The stock’s fifty day moving average is $91.00 and its two-hundred day moving average is $95.75.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.